Massive european study tracks hemophilia in kids to unlock better care
NCT ID NCT02979119
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This registry collects health data from 4,000 children with hemophilia A or B across Europe. Researchers track bleeding episodes, joint health, and antibody development to clotting factors. The goal is to understand long-term outcomes and improve treatment for this rare bleeding disorder.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this registry could provide insights that improve treatment strategies for children with hemophilia.
- What could go wrong
- This is an observational registry, not a treatment trial. It cannot directly test new therapies or guarantee better outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 4,000 people
The number the study aims to enrol. It can still change while the study runs.
- Start date
-
Jun 2014
- Expected to finish
-
Dec 2039
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Children with mild ( FVIII/IX 6 to 25%), moderate (FVIII/IX 1 to 5%) or severe (FVIII/IX \<1%) haemophilia A or B, born from January 1st 2000 until January 1st 2030 who have been or are to be treated in one of the participating centres
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosed with Haemophilia A or B * Factor VIII/ IX activity of \<1 to 25% * Complete records of Factor treatment and bleeds * Treated in one of the participating centres Exclusion Criteria: * Patients referred because of an inhibitor\* * Informed consent not obtained
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Factor ix deficiency are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
34 sites in 19 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
A. Bianchi Bonomi Hemophilia and Thrombosis Centre IRCCS Ca' Granda Ospedale Maggiore Policlinico
COMPLETEDMilan, 20122, Italy
-
Azienda Ospedaliero Universitaria Careggi
RECRUITINGFlorence, Italy
-
Birmingham Children's Hospital NHS Trust - Department of Haematology
RECRUITINGBirmingham, United Kingdom
-
Centre de traitement des hémophiles Hôpital Universitaire Purpan
RECRUITINGToulouse, F-31052, France
-
Centro Hospitalar São João, S. Imuno-hemoterapia
RECRUITINGPorto, Portugal
-
Charité Campus Virchow Klinikum, Klinik für Pädiatrie m.S. Onkologie und Hämatologie
RECRUITINGBerlin, Germany
-
Children's Health Ireland (CHI) at Crumlin
RECRUITINGDublin, Ireland
-
Children's Hospital Helsinki University Hospital
RECRUITINGHelsinki, FIN-00029, Finland
-
Department of Haematology Royal Hospital for Sick Children
RECRUITINGGlasgow, G 3885, United Kingdom
-
Department of Internal Medicine, Hemophilia Treatment Center, Vivantes Klinikum im Friedrichshain
RECRUITINGBerlin, Germany
-
Department of Paediatric Haematology/oncology - University Hospital Motol
RECRUITINGPrague, 150 06, Czechia
-
Department of Pediatrics Århus Kommunehospital Skejby Sygehus
RECRUITINGAarhus, DK-8200, Denmark
-
Department of Pediatrics, Clinic of Coag. Disorders Karolinska Hospital
RECRUITINGStockholm, S-17176, Sweden
-
Division of Haematology/Oncology Hospital for Sick Children
RECRUITINGToronto, M5G-1X8, Canada
-
Division of Hematology/Oncology Hôpital St Justine
RECRUITINGMontreal, H3T 1C5, Canada
-
Dr. v. Haunersches Kinderspital University of Munich
RECRUITINGMunich, D-80337, Germany
-
Gaslini Hospital
RECRUITINGGenova, I-16184, Italy
-
Haemophila Center Great Ormond Street Hospital for Children
COMPLETEDLondon, WC1N3JH, United Kingdom
-
Haemophilia Comprehensive Care Centre, Centre for Thrombosis and Haemostasis Children's University Hospital Brno
RECRUITINGBrno, 613 00, Czechia
-
Haemophilia-Haemostasis Unit St. Sophia Children's Hospital
RECRUITINGAthens, GR-11527, Greece
-
Hospital General Unidad de Hemofilia 1 Sur Hospitales Universitarios Virgen del Rocio
COMPLETEDSeville, 41013, Spain
-
Hämophilie Zentrum Rhein Main
RECRUITINGFrankfurt, D-60596, Germany
-
Inselspital Bern, University Children's Hospital
RECRUITINGBern, Switzerland
-
Institut für Experimentelle Hämatologie und Transfusionsmedizin Universitätsklinikum Bonn
RECRUITINGBonn, D-53127, Germany
-
Klinik Bremen-Mitte Prof.-Hess-Kinderklinik
RECRUITINGBremen, D 28177, Germany
-
Lund University Hospital
RECRUITINGMalmö, S-20502, Sweden
-
Medical University of Vienna - Department of Paediatrics
RECRUITINGVienna, Austria
-
Oslo University Hospital
NOT_YET_RECRUITINGOslo, Norway
-
Royal Hospital for Sick Children
COMPLETEDEdinburgh, EH9 1LF, United Kingdom
-
Service Hématologique Centre Regional Traitement d'Hemophilie Bicetre
RECRUITINGLe Kremlin-Bicêtre, F-94270, France
-
Service d'Hématologie Pédiatrique Hôpital Universitaire La Timone
RECRUITINGMarseille Cedex-05, F-13385, France
-
Service of Pediatric Haematology University Hospital Leuven
RECRUITINGLeuven, B-3000, Belgium
-
The National Hemophilia Center Sheba Medical Center, Tel Hashomer
RECRUITINGRamat Gan, 52621, Israel
-
Unidad de Coagulopatias Congenitas Hospital Universitario la Fe
RECRUITINGValencia, 46009, Spain
-
Unidad de Coagulopatías Hospital Universitario La Paz
RECRUITINGMadrid, 28046, Spain
-
Unitat Hemofilia Hospital Vall d'Hebron
RECRUITINGBarcelona, 08035, Spain
-
University Hospital Frankfurt & Goethe University - Clinical and Molecular Hemostasis, Department of Pediatrics
RECRUITINGFrankfurt am Main, Germany
-
Universitäts-Klinik für Kinder- und Jugendheilkunde
COMPLETEDGraz, A-8036, Austria
-
Van Creveld Kliniek University Medical Center Utrecht
RECRUITINGUtrecht, 3508 GA, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.